PubMed

Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group.

Malmstrom K, Rodriguez-Gomez G, Guerra J, Villaran C, Piñeiro A, Wei LX, Seidenberg BC, Reiss TF.

Ann Intern Med. 1999 Mar 16;130(6):487-95.PMID: 10075616 [PubMed - indexed for MEDLINE]Related articlesFree article

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.

Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, Michele TM, Reiss TF, Nguyen HH, Bratton DL.

Pediatrics. 2001 Sep;108(3):E48.PMID: 11533366 [PubMed - indexed for MEDLINE]Related articlesFree article

Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group.

Reiss TF, Chervinsky P, Dockhorn RJ, Shingo S, Seidenberg B, Edwards TB.

Arch Intern Med. 1998 Jun 8;158(11):1213-20.PMID: 9625400 [PubMed - indexed for MEDLINE]Related articlesFree article

Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group.

Laviolette M, Malmstrom K, Lu S, Chervinsky P, Pujet JC, Peszek I, Zhang J, Reiss TF.

Am J Respir Crit Care Med. 1999 Dec;160(6):1862-8.PMID: 10588598 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older.

Williams B, Noonan G, Reiss TF, Knorr B, Guerra J, White R, Matz J.

Clin Exp Allergy. 2001 Jun;31(6):845-54.PMID: 11422148 [PubMed - indexed for MEDLINE]Related articles

Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group.

Noonan MJ, Chervinsky P, Brandon M, Zhang J, Kundu S, McBurney J, Reiss TF.

Eur Respir J. 1998 Jun;11(6):1232-9.PMID: 9657560 [PubMed - indexed for MEDLINE]Related articlesFree article

Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).

Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening A, Haahtela T, Holgate ST, Picado C, Leff JA.

Respir Med. 2000 Jun;94(6):612-21.PMID: 10921768 [PubMed - indexed for MEDLINE]Related articles

Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone.

Baumgartner RA, Martinez G, Edelman JM, Rodriguez Gomez GG, Bernstein M, Bird S, Angner R, Polis A, Dass SB, Lu S, Reiss TF; Montelukast Asthma Study Group.

Eur Respir J. 2003 Jan;21(1):123-8.PMID: 12570120 [PubMed - indexed for MEDLINE]Related articlesFree article

Montelukast: a review of its therapeutic potential in persistent asthma.

Jarvis B, Markham A.

Drugs. 2000 Apr;59(4):891-928. Review.PMID: 10804041 [PubMed - indexed for MEDLINE]Related articles

A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group.

Altman LC, Munk Z, Seltzer J, Noonan N, Shingo S, Zhang J, Reiss TF.

J Allergy Clin Immunol. 1998 Jul;102(1):50-6.PMID: 9679847 [PubMed - indexed for MEDLINE]Related articles

Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.

Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.

Clin Ther. 2008 Aug;30(8):1492-504.PMID: 18803991 [PubMed - indexed for MEDLINE]Related articles

A randomized study comparing the effect of loratadine added to montelukast with montelukast, loratadine, and beclomethasone monotherapies in patients with chronic asthma.

Lu S, Liu N, Dass SB, Reiss TF.

J Asthma. 2009 Jun;46(5):465-9.PMID: 19544166 [PubMed - indexed for MEDLINE]Related articles

Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma.

Price DB, Hernandez D, Magyar P, Fiterman J, Beeh KM, James IG, Konstantopoulos S, Rojas R, van Noord JA, Pons M, Gilles L, Leff JA; Clinical Outcomes with Montelukast as a Partner Agent to Corticosteroid Therapy (COMPACT) International Study Group.

Thorax. 2003 Mar;58(3):211-6.PMID: 12612295 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of montelukast, a once-daily leukotriene receptor antagonist, on peak expiratory flow variability.

Zhang J, Yu C, Noonan G, Reiss TF.

Clin Ther. 2002 Apr;24(4):574-82.PMID: 12017402 [PubMed - indexed for MEDLINE]Related articles

Comparative efficacy of once-daily therapy with inhaled corticosteroid, leukotriene antagonist or sustained-release theophylline in patients with mild persistent asthma.

Yurdakul AS, Taci N, Eren A, Sipit T.

Respir Med. 2003 Dec;97(12):1313-9.PMID: 14682413 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of low-dose fluticasone propionate compared with montelukast for maintenance treatment of persistent asthma.

Meltzer EO, Lockey RF, Friedman BF, Kalberg C, Goode-Sellers S, Srebro S, Edwards L, Rickard K; Fluticasone Propionate Clinical Research Study Group.

Mayo Clin Proc. 2002 May;77(5):437-45.PMID: 12004993 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma.

Vaquerizo MJ, Casan P, Castillo J, Perpiña M, Sanchis J, Sobradillo V, Valencia A, Verea H, Viejo JL, Villasante C, Gonzalez-Esteban J, Picado C; CASIOPEA (Capacidad de Singulair Oral en la Prevencion de Exacerbaciones Asmaticas) Study Group.

Thorax. 2003 Mar;58(3):204-10. Erratum in: Thorax. 2003 Apr;58(4):370. PMID: 12612294 [PubMed - indexed for MEDLINE]Related articlesFree article

Spotlight on montelukast in asthma in children 2 to 14 years of age.

Muijsers RB, Noble S.

Am J Respir Med. 2002;1(3):225-8. Review.PMID: 14720060 [PubMed - indexed for MEDLINE]Related articles

Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients.

Dockhorn RJ, Baumgartner RA, Leff JA, Noonan M, Vandormael K, Stricker W, Weinland DE, Reiss TF.

Thorax. 2000 Apr;55(4):260-5.PMID: 10722763 [PubMed - indexed for MEDLINE]Related articlesFree article

Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients.

Tohda Y, Fujimura M, Taniguchi H, Takagi K, Igarashi T, Yasuhara H, Takahashi K, Nakajima S.

Clin Exp Allergy. 2002 Aug;32(8):1180-6.PMID: 12190656 [PubMed - indexed for MEDLINE]Related articles